Abiopharma

GRI Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference

New Form 8-K - Nuwellis, Inc. Filed: 2025-09-03 AccNo: 0001140361-25-033738 Size: 439 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form 8-K - electroCore, Inc. Filed: 2025-09-03 AccNo: 0001641172-25-026318 Size: 280 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 7.01: Regulation FD Disclosure Item …

New Form 424B5 - Nuwellis, Inc. Filed: 2025-09-03 AccNo: 0001140361-25-033737 Size: 624 KB

New Form 8-K - ADIAL PHARMACEUTICALS, INC. Filed: 2025-09-03 AccNo: 0001213900-25-083719 Size: 229 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 9.01: Financial Statements and Exhibits

ImmunoPrecise - ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”

ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”

Artelo Biosciences Announces Positive Interim Phase 2 CAReSResults for the Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)

Artelo Biosciences Announces Positive Interim Phase 2 CAReS Results for the Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)

New Form 6-K - NuCana plc Filed: 2025-09-03 AccNo: 0001193125-25-194556 Size: 20 KB

New Form 424B5 - STRATA Skin Sciences, Inc. Filed: 2025-09-03 AccNo: 0001213900-25-083714 Size: 287 KB

Outlook Therapeutics to Present at the 2025 EURETINA Innovation Spotlight (EIS)

Coherus Oncology to Participate in Upcoming Investor Conferences

DarioHealth Issues Shareholder Update: Multi-Condition Leadership in Momentum Driven Digital Health Market

Journey Medical Corporation to Participate in September 2025 Investor Conferences